drugset / Trial / NCT01010308
Nadolol for Proliferating Infantile Hemangiomas
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to explore the efficacy and safety of Nadolol in hemangiomas of infancy. The secondary objective is to assess the feasibility of conducting a randomized controlled trial comparing nadolol with corticosteroids and propranolol.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-05
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nadolol | Unknown | 2 mg/kg | Oral |